INDSWFTLABBSEIND SWIFT LABORATORIES LT· Pharmaceuticals & BiotechnologyHighNeutral
Announced Thu, 8 Oct, 2026 · 18:40 IST

Warrant conversion: 14 lakh shares allotted to promoter group firm Essix Biosciences

Warrants ConvertedFund Raising View source PDFExplain this filing

INDSWFTLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+0.8%Reaction day
₹365.80
prior close
₹367.00
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.3%+0.6% vs market
Pharmaceuticals peers, median of 168sector-0.2%+1.0% vs sector

On the reaction day the stock moved 0.6 pts more than Nifty Microcap 250 and 1.0 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+1.4
10m
-1.1
15m
+0.6
30m
+0.4
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+0.8+0.3+0.6-0.2+1.0
Next day
-1.0+1.1-2.2-0.2-0.8
2d
-1.1+1.3-2.4-0.4-0.7
3d
+1.0+2.0-1.0-0.7+1.7
4d
-2.4+0.3-2.7-1.1-1.3
5d
-1.9+1.1-3.0-0.8-1.1
1w
-6.4-3.2-3.2-4.1-2.3
15d
—————
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 168Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Ind-Swift Laboratories' Preferential Issue Committee on Oct 8, 2026 approved allotment of 14 lakh equity shares upon conversion of 14 lakh fully convertible warrants to promoter group firm Essix Biosciences. Warrants were originally issued on Sept 17, 2026 at Rs 196 per share. The promoter paid the balance 75 percent of Rs 147 per share, aggregating to about Rs 20.58 crore. Paid-up equity capital rose from Rs 86.71 crore to Rs 86.96 crore, with total shares now at about 8.70 crore.

Likely market impact

Promoter group entity converted warrants into shares, increasing promoter holding. Capital base expands; no fresh external dilution beyond the promoter.